About this trial

Substance use disorders (SUD) and attention deficit disorder with or without hyperactivity (ADHD) are frequently co-morbid, particularly among people under court supervision. The coexistence of these disorders increases the social and legal vulnerability of individuals. Better identification of ADHD in vulnerable people with SUD is essential to improving their care. This project aims to provide appropriate support for this at-risk population.

Eligibility criteria

Qualifiers

Adult, under the supervision of the justice system or monitored by a correctional facility

Diagnosis of Substance Use Disorder (SUD)

Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD)

No objection from the patient

Disqualifiers

Severe or decompensated psychiatric disorders

Severe cognitive impairment

Lack of understanding of the French language

Refusal to participate

Trial design

Treatments tested in this trial

  • Workshop

Treatment groups

39 Participants
are divided into 1 treatment group

Locations

1
CHU Brest29200, Brest France

Sponsors and collaborators

University Hospital, Brest

Lead sponsor